MOLECULAR DEVICES LLC.

History

Year	Detail
1983	Molecular Devices was founded by Harden McConnell, a physical and biophysical chemist known for incisive contributions in theory and experiment.
1995	Molecular Devices acquired FLIPR technology for high-throughput screening of G protein-coupled receptors (GPCRs).
2003	Molecular launched SoftMax, the first plate reader GxP feature software for regulated labs.
2005	Molecular launched the ImageXpress Micro system, the first automated high-content imager for research and screening.
2010	Danaher Corp, a science and technology innovator helping customers solve complex challenges, acquired Molecular Devices.
2019	Molecular Devices opened a newly expanded $1M Research & Development Center near Salzburg, Austria, to develop their growing biotech community in the Salzburg area.
2021	Ananda Devices and Molecular Devices launched a strategic collaboration to automate imaging and customize analysis of the nervous system on a chip.
2022	Molecular Devices and HeartBeat.bio collaborated to automate and scale cardiac organoids for high-throughput screening in drug discovery.
2023	Molecular Devices partnered with SEED Biosciences to offer the DispenCell Single-Cell Dispenser, which isolates single cell lines three times faster and cheaper than existing solutions.
2024	Molecular Devices launched QPix Insights, a software solution to streamline and enhance microbial colony analysis.